Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546

Related Posts

Our Mission: Innovating to Protect Humanity from the Global Threat of Antimicrobial Resistance: Integrating Solutions Across Human and Veterinary Medicine, Stewardship, and Awareness


The Levy CIMAR’s own Dr. Andrew Camilli, a Professor of Molecular Biology and Microbiology at the Tufts University School of Medicine, will present on “Phage Prophylaxis of Cholera.” Bacteriophages are viruses that specifically target and kill bacteria, preventing bacterial infections, […]


Erin Duffy, PhD, is Chief of Research and Development at the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X—a global partnership hosted at Boston University that is focused on supporting developers of promising new antibiotics, diagnostics, and vaccines that tackle the […]


Edward Geisinger, MD, PhD, an Assistant Professor of Biology at Northeastern University in Boston and an Affiliate member of the Levy CIMAR, will present for our November 2021 Science Lunch. Check back soon for more information on the talk. Dr. […]

As @G7 Health Ministers recognize the urgency to curb the growing #AMR crisis in their latest
communique, the #AMR Preparedness Index couldn’t be timelier. Check who is leading and who
is falling behind: https://t.co/u4B1q86KQF #2021AMRIndex #WeAreID @LevyCIMAR @IDSAInfo

Congress needs to fix the broken market for antibiotics⁩ ⁦@LevyCIMAR⁩ ⁦@IDSAInfo⁩ ⁦@ARLGnetwork⁩ ⁦@CARB_X⁩ ⁦@Wellcome_AMR⁩ https://t.co/tm3YlrxdhQ

Load More...